These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3281997)

  • 1. The effect of ketotifen on bronchial beta-adrenergic tachyphylaxis in normal human volunteers.
    Pauwels R; Van der Straeten M
    J Allergy Clin Immunol; 1988 Apr; 81(4):674-80. PubMed ID: 3281997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
    Lipworth BJ; Struthers AD; McDevitt DG
    Am Rev Respir Dis; 1989 Sep; 140(3):586-92. PubMed ID: 2782734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bronchial adrenergic receptors and asthma. Tachyphylaxis and its prevention].
    Pauwels R
    Allerg Immunol (Paris); 1988 Sep; 20(7):261-5. PubMed ID: 2846002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ketotifen on the bronchodilation induced by salbutamol.
    Carpentiere G; Marino S; Castello F; Bonanno CT; Baldanza C
    Respiration; 1988; 54(3):190-2. PubMed ID: 3247518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis.
    Ullman A; Hedner J; Svedmyr N
    Am Rev Respir Dis; 1990 Sep; 142(3):571-5. PubMed ID: 1975162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
    Cockcroft DW; Swystun VA; Bhagat R
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of ketotifen on beta-adrenergic activity in asthmatics.
    Gove RI; Burge PS; Stableforth DE; Skinner C
    Eur J Clin Pharmacol; 1988; 34(6):585-9. PubMed ID: 2844549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective subsensitization of beta-adrenergic receptors in central airways of asthmatics and normal subjects during long-term therapy with inhaled salbutamol.
    Conolly ME; Tashkin DP; Hui KK; Littner MR; Wolfe RN
    J Allergy Clin Immunol; 1982 Dec; 70(6):423-31. PubMed ID: 6292279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Adrenergic tachyphylaxis in the rat and its reversal and prevention by ketotifen.
    Bretz U; Martin U; Mazzoni L; Ney UM
    Eur J Pharmacol; 1983 Jan; 86(3-4):321-8. PubMed ID: 6131826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo.
    Cockcroft DW; Davis BE; Swystun VA; Marciniuk DD
    J Allergy Clin Immunol; 1999 Jun; 103(6):1049-53. PubMed ID: 10359885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
    Lipworth BJ; Clark DJ; Koch P; Arbeeny C
    Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant administration of low-dose prednisolone protects against in vivo beta2-adrenoceptor subsensitivity induced by regular formoterol.
    Tan KS; McFarlane LC; Lipworth BJ
    Chest; 1998 Jan; 113(1):34-41. PubMed ID: 9440565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect on beta adrenergic receptors of tachyphylaxis on the sensitivity of smooth muscle in the bronchi to beta adrenergic receptor agonists in bronchial asthma].
    Passowicz-Muszyńska E
    Pol Tyg Lek; 1990 Jul 16-30; 45(29-31):608-11. PubMed ID: 1963682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does tachyphylaxis occur to the non-pulmonary effects of salmeterol?
    Maconochie JG; Minton NA; Chilton JE; Keene ON
    Br J Clin Pharmacol; 1994 Feb; 37(2):199-204. PubMed ID: 7910472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response.
    Bhagat R; Swystun VA; Cockcroft DW
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):47-52. PubMed ID: 8568137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
    Becker AB; Simons FE
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Formoterol as inhalation powder in the treatment of patients with reversible obstructive lung diseases. A 3-month placebo-controlled comparison of the effects of formoterol and salbutamol, followed by a 12-month period with formoterol alone].
    Steffensen IE; Faurschou P
    Ugeskr Laeger; 1996 Dec; 158(49):7092-6. PubMed ID: 8999618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.
    Schäfers RF; Karl I; Mennicke K; Daul AE; Philipp T; Brodde OE
    Br J Clin Pharmacol; 1999 Jan; 47(1):59-66. PubMed ID: 10073741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.